The development and widespread availability of recombinant products will effect blood centers through reduced product use, replacement of current products, and novel applications of new products. The greatest amount of clinical experience to date has dealt with the use of recombinant human erythropo
โฆ LIBER โฆ
Ribozymes: biology, biochemistry, and implications for clinical medicine
โ Scribed by M. Kiehntopf; E. L. Esquivel; M. A. Brach; F. Herrmann
- Publisher
- Springer
- Year
- 1995
- Tongue
- English
- Weight
- 700 KB
- Volume
- 73
- Category
- Article
- ISSN
- 0946-2716
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Cytokine biology. Implications for trans
โ
John W. Adamson
๐
Article
๐
1991
๐
John Wiley and Sons
๐
English
โ 400 KB
Protein kinase CK2: a catalyst for biolo
โ
Khalil Ahmed; Olaf-Georg Issinger; Karsten Niefind
๐
Article
๐
2011
๐
Springer
๐
English
โ 131 KB
Designing laboratory exercises for the u
โ
Kenneth M. Weinlander; David J. Hall
๐
Article
๐
2010
๐
The American Society for Biochemistry and Molecula
๐
English
โ 497 KB
๐ 2 views
## Abstract Personalized medicine refers to medical care that involves genetically screening patients for their likelihood to develop various disorders. Commercial genome screening only involves identifying a consumer's genotype for a few single nucleotide polymorphisms. A phenotype (such as an ill
Androgens: Basic Biology and Clinical Im
โ
E.S. Orwoll
๐
Article
๐
2001
๐
Springer
๐
English
โ 217 KB
Pharmacogenomics and perioperative medic
โ
Jerry H. Kim; Debra A. Schwinn; Ruth Landau
๐
Article
๐
2008
๐
Springer-Verlag
๐
French
โ 751 KB
Update on endothelins โ biology and clin
โ
Tracy E. Hunley; V. Kon
๐
Article
๐
2001
๐
Springer
๐
English
โ 118 KB